Key Points:
- With the Galaxy Watch 7, Samsung may launch an innovative algorithm-based AFib detection feature, which can be literally (e)life-saving.
- A new revelation on a patent shows Samsung is dedicated to creating an AI-accurate AFib detection system, however, the availability of this feature on Galaxy Watch 7 is subject to speculation.
- Integration of Generative AI will enable the gadget to read the PPG signals as ECG and may further enhance the precision and reliability of the device.
In a really exciting novelty with Samsung Company striving to be always up to date and a leader in wearable health technology AFib monitoring for the nearing best-selling Galaxy 7 may be AI-powered. Grasped from the filling of a patent application is the recent intuition of Samsunga’s use of AI technology to achieve precise AFib detection to the benefit of customers.
The fact that this function may have a role to play in the upcoming Galaxy Watch 7 is still a matter of speculation. However, the significance of this attribute towards public health is immense. The arrhythmia known as atrial fibrillation (AFib), with the rhythm irregularly quicker than usual is a life-threatening condition that possibly could be the cause of warning signs seen in the reports from the CDC.
On the other hand, consumers are already looking forward to more advanced health features such as non-invasive blood glucose monitoring, which will mean that the Galaxy Watch 7 could dethrone the market leader after their innovation. As Samsung is chipping away at the frontiers of technology, crossroads where lead are pieces of technology that dispense with people’s health turns out to be a future where wearable devices become not dispensable in the safeguarding of health.
